Medication info

Cipronin Tablets (Ciprofloxacin Hydrochloride Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Anguk New Pharm Co., Ltd.
Appearance
White circular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201902960 · Approved 2019.05.08

This product's status changed to Expired on 2024.05.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of genitourinary, respiratory, ear, nose and throat, gastrointestinal, skin, osteoarticular, and eye infections
Who takes it
Adults
Adult dose
○ Usual adult dose: Administer ciprofloxacin 250 ~ 500 mg per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in severe renal impairment; however, monitor the patient's condition closely after administration. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Anguk New Pharm Co., Ltd.

Efficacy & effects

Treatment of genitourinary, respiratory, ear, nose and throat, gastrointestinal, skin, osteoarticular, and eye infections

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medication is effective against various bacteria such as Escherichia coli, Shigella, and Salmonella, and is used for respiratory infections excluding acute bronchitis and community-acquired pneumonia. It is also effective for infections of the ear, nose, and throat, bacterial prostatitis, complicated urinary tract infections, gonococcal cervicitis, and urethritis. It is also used for gastrointestinal infections, bile duct infections, skin and soft tissue infections, and osteoarticular infections. This drug is helpful in the treatment of infections in various areas such as gynecological infections, peritonitis, suppurative adenitis, and sebaceous gland inflammation. However, due to the nature of fluoroquinolones, there is a risk of serious adverse reactions, so caution is advised to use it only when no alternative treatment exists for mild diseases. Overall, it is safely and effectively used for the treatment of broad-spectrum bacterial infections.

How to take

Adult dose

○ Usual adult dose: Administer ciprofloxacin 250 ~ 500 mg per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in severe renal impairment; however, monitor the patient's condition closely after administration. Adjust the dose appropriately according to symptoms.

Precautions

This drug may cause serious side effects such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system abnormalities, so caution is required. In particular, it is advisable not to use it in patients with myasthenia gravis as symptoms may worsen. This drug is used only for specific infections and should only be administered when no other treatment options are available. The elderly, patients with impaired renal function, and those with seizures should be especially cautious when using this drug. It should not be used in pregnant or breastfeeding women, adolescents under 18, and patients with known allergies to this drug or similar drugs. This drug may interact with other medications, so it is essential to inform healthcare providers of any concurrently used medications. If pain or inflammation occurs in the tendons during treatment, use should be discontinued immediately, and rest should be taken, avoiding strenuous exercise. This drug may affect the central nervous system, so care should be taken when driving or operating machinery. Additionally, since it may affect blood sugar control, diabetic patients should monitor their blood sugar levels regularly. Overdose may cause kidney damage, so the prescribed dosage and amounts must be strictly followed. The medication should be stored away from direct sunlight and out of reach of children.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, decrease in hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR values, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reaction, shock resembling anaphylaxis, serum sickness-like reaction, loss of appetite, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory reduction, loss of taste, tremors, convulsions, vertigo, delirium, seizures, drowsiness, migraine, coordination difficulties, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, ataxia, polyneuropathy, visual disturbances, chromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, appetite loss, gastrointestinal discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis with blood in stool, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver impairment, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, hematuria, crystalluria, interstitial nephritis, vulvovaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbance, maculopapular rash, purpuric rash, acute renal failure, shock, hypotension, chest tightness, elevated creatine kinase, increased myoglobin in blood and urine, rhabdomyolysis, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, visual impairment, aortic aneurysm, aortic dissection, valvular regurgitation, valvular incompetence

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it should be kept at a temperature between 1 and 30 degrees Celsius. Therefore, it is advisable to avoid places that are too hot or cold and to place it where appropriate temperatures can be maintained.

Appearance and packaging

Appearance

White circular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.